See also our related blog for the Pediatric Preclinical Testing Initiative.

Wednesday, May 15, 2013

Proof-of-concept rare cancers in drug development: the case for rhabdomyosarcoma

We hope you will enjoy this review and commentary as much as we do.  A lot of people in pharma, the community-at-large and scientific thought leaders helped to create this somewhat out of the box concept proposal.  With some additional community volunteers, I think we could really put this plan to action.  Sincerely, Charles
[ This review was made possible by a gift from the Ethan Jostad Foundation ].